31.82
2.48%
0.77
Avidity Biosciences Inc (RNA) 재무 분석
손익 계산서
분기별
*모든 숫자는 백만 단위입니다.
기간 종료일 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 |
기간 | 3개월 | 3개월 | 3개월 | 3개월 | 3개월 |
Revenues |
61.56%
3.543
|
2.193 | 2.818 | 2.316 | 2.233 |
Operating Expenses
|
17.11%
80.73
|
68.94 | 61.44 | 54.95 | 59.83 |
Benefits Costs and Expenses |
15.59%
72.40
|
62.64 | - | - | 54.63 |
Costs And Expenses |
15.59%
72.40
|
62.64 | 61.44 | 54.95 | 54.63 |
Operating Income/Loss |
15.65%
-77.19
|
-66.74 | -58.62 | -52.63 | -57.60 |
Nonoperating Income/Loss |
32.25%
8.332
|
6.30 | 6.267 | 5.609 | 5.202 |
Income/Loss From Continuing Operations Before Tax |
13.92%
-68.86
|
-60.44 | 2.818 | -47.02 | -52.39 |
Income/Loss From Continuing Operations After Tax |
13.92%
-68.86
|
-60.44 | -52.36 | -47.02 | -52.39 |
Net Income/Loss
|
13.92%
-68.86
|
-60.44 | -52.36 | -47.02 | -52.39 |
Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
Basic Average Shares |
8,408%
87.21
|
1.025 | 74.10 | 71.39 | 70.43 |
Diluted Average Shares |
8,408%
87.21
|
1.025 | 74.10 | 71.39 | 70.43 |
Basic Earnings Per Share |
1.25%
-0.79
|
-0.80 | -0.71 | -0.66 | -0.74 |
Diluted Earnings Per Share |
1.25%
-0.79
|
-0.80 | -0.71 | -0.66 | -0.74 |
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
자본화:
|
볼륨(24시간):